ZIM
CDMO

Zacks Investment Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Zacks Investment Management’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-19,163
Closed -$107K – 595
2019
Q2 		$107K Buy
+19,163
New +$79K ﹤0.01% 511
2015
Q3 		– Sell
-21,172
Closed -$194K – 683
2015
Q2 		$194K Buy
21,172
+3,663
+21% +$35.2K 0.01% 599
2015
Q1 		$165K Buy
+17,509
New +$169K 0.01% 603
2014
Q3 		– Sell
-33,096
Closed -$436K – 761
2014
Q2 		$436K Buy
+33,096
New +$417K 0.02% 481

Other funds holding CDMO

ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Zacks Investment Management's CDMO Position: Q3 2019 in Review

Zacks Investment Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q3 2019, closing a stake of 19,163 shares — an estimated $107K sold.

Zacks Investment Management first reported a position in CDMO in Q2 2014 and held it in 4 quarters. The position peaked at $436K in Q2 2014. 99 funds tracked by Wall St. Rank hold CDMO as of Q3 2019.

  • Zacks Investment Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Zacks Investment Management sold 19,163 Avid Bioservices, Inc. Common Stock shares in Q3 2019, an estimated $107K.
  • Zacks Investment Management first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2014 and held it in 4 quarters.
  • Zacks Investment Management's Avid Bioservices, Inc. Common Stock position peaked at $436K in Q2 2014.
  • 99 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q3 2019.

Based on Zacks Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.